rs144252036

Variant summary

Our verdict is Benign. The variant received -15 ACMG points: 0P and 15B. BP4_ModerateBP6_Very_StrongBP7BS2

The NM_005629.4(SLC6A8):​c.1020C>T​(p.Asp340Asp) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000736 in 1,209,311 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 21 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.00022 ( 0 hom., 4 hem., cov: 24)
Exomes 𝑓: 0.000058 ( 0 hom. 17 hem. )

Consequence

SLC6A8
NM_005629.4 synonymous

Scores

1
1
8

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -1.55

Publications

0 publications found
Variant links:
Genes affected
SLC6A8 (HGNC:11055): (solute carrier family 6 member 8) The protein encoded by this gene is a plasma membrane protein whose function is to transport creatine into and out of cells. Defects in this gene can result in X-linked creatine deficiency syndrome. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2008]
SLC6A8 Gene-Disease associations (from GenCC):
  • creatine transporter deficiency
    Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Orphanet, ClinGen, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -15 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.07809362).
BP6
Variant X-153693465-C-T is Benign according to our data. Variant chrX-153693465-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 379434.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-1.55 with no splicing effect.
BS2
High Hemizygotes in GnomAd4 at 4 XL gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_005629.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SLC6A8
NM_005629.4
MANE Select
c.1020C>Tp.Asp340Asp
synonymous
Exon 7 of 13NP_005620.1
SLC6A8
NM_001142806.1
c.675C>Tp.Asp225Asp
synonymous
Exon 7 of 13NP_001136278.1
SLC6A8
NM_001142805.2
c.1017-27C>T
intron
N/ANP_001136277.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SLC6A8
ENST00000253122.10
TSL:1 MANE Select
c.1020C>Tp.Asp340Asp
synonymous
Exon 7 of 13ENSP00000253122.5
SLC6A8
ENST00000457723.1
TSL:5
c.4C>Tp.Arg2Cys
missense
Exon 1 of 3ENSP00000394742.1
SLC6A8
ENST00000430077.6
TSL:2
c.675C>Tp.Asp225Asp
synonymous
Exon 7 of 13ENSP00000403041.2

Frequencies

GnomAD3 genomes
AF:
0.000224
AC:
25
AN:
111684
Hom.:
0
Cov.:
24
show subpopulations
Gnomad AFR
AF:
0.000781
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000188
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000125
AC:
23
AN:
183363
AF XY:
0.0000884
show subpopulations
Gnomad AFR exome
AF:
0.00106
Gnomad AMR exome
AF:
0.0000729
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0000722
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000244
Gnomad OTH exome
AF:
0.000221
GnomAD4 exome
AF:
0.0000583
AC:
64
AN:
1097577
Hom.:
0
Cov.:
32
AF XY:
0.0000468
AC XY:
17
AN XY:
362975
show subpopulations
African (AFR)
AF:
0.00110
AC:
29
AN:
26390
American (AMR)
AF:
0.000142
AC:
5
AN:
35203
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19381
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30202
South Asian (SAS)
AF:
0.0000554
AC:
3
AN:
54132
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
40526
Middle Eastern (MID)
AF:
0.000243
AC:
1
AN:
4113
European-Non Finnish (NFE)
AF:
0.0000309
AC:
26
AN:
841568
Other (OTH)
AF:
0.00
AC:
0
AN:
46062
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.461
Heterozygous variant carriers
0
3
6
9
12
15
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000224
AC:
25
AN:
111734
Hom.:
0
Cov.:
24
AF XY:
0.000118
AC XY:
4
AN XY:
33912
show subpopulations
African (AFR)
AF:
0.000780
AC:
24
AN:
30787
American (AMR)
AF:
0.00
AC:
0
AN:
10570
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2645
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3561
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2649
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
6050
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
218
European-Non Finnish (NFE)
AF:
0.0000188
AC:
1
AN:
53051
Other (OTH)
AF:
0.00
AC:
0
AN:
1518
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.520
Heterozygous variant carriers
0
1
3
4
6
7
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000285
Hom.:
0
Bravo
AF:
0.000310
ESP6500AA
AF:
0.00104
AC:
4
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.000140
AC:
17
EpiCase
AF:
0.0000545
EpiControl
AF:
0.00

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Creatine transporter deficiency Benign:1
Nov 18, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Inborn genetic diseases Benign:1
May 02, 2019
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.

not provided Benign:1
May 25, 2021
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.18
BayesDel_addAF
Benign
-0.42
T
BayesDel_noAF
Benign
-0.42
CADD
Benign
1.0
DANN
Benign
0.79
FATHMM_MKL
Benign
0.37
N
MetaRNN
Benign
0.078
T
MetaSVM
Benign
-0.37
T
PhyloP100
-1.6
PROVEAN
Pathogenic
-8.0
D
REVEL
Benign
0.20
Sift4G
Uncertain
0.014
D
MVP
0.79
ClinPred
0.12
T
GERP RS
-4.4
PromoterAI
-0.094
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Mutation Taster
=97/3
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.090
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs144252036; hg19: chrX-152958920; API